Annual Report

Overview

The report describes record 2023 results, including operating income of RMB8.222 billion and profit attributable to shareholders of RMB987 million. It highlights the Company's traditional Chinese medicine portfolio, quality traceability systems, GAP traceability and lean intelligent manufacturing. The sustainability section identifies energy, water, emissions, effluents and waste, occupational health and safety, diversity and customer health and safety as relevant topics, with a Sustainability task force assigned to oversee reporting. A standalone 2023 Sustainability Report was stated to be forthcoming in May 2024.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2023
Period: 1 January 2023 – 31 December 2023
Language: English
Pages
File size

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services